Apr 27, 2012 ... By Bill Berkrot NEW YORK, April 27 (Reuters) - Men with erectile dysfunction may not have to plan for sex as far in advance anymore after Vivus ...
www.huffingtonpost.com/2012/04/27/fda-approves-vivus-viagra-rival...
Mar 30, 2012 ... NEW YORK — Stocks that moved substantially or traded heavily Friday on the New York Stock Exchange and Nasdaq Stock Market: NYSE ...
www.huffingtonpost.com/huff-wires/20120330/us-wall-street-stocks/
Feb 23, 2012 ... NEW YORK — Stocks that moved substantially or traded heavily Thursday on the New York Stock Exchange and Nasdaq Stock Market: NYSE ...
www.huffingtonpost.com/huff-wires/20120223/us-wall-street-stocks/
Feb 22, 2012 ... SILVER SPRING, Md., Feb 22 (Reuters) - Proponents of a new obesity medication from Vivus Inc told U.S. reviewers on Wednesday that the ...
www.huffingtonpost.com/2012/02/22/qnexa-obesity-drug_n_1294465.ht...
Feb 22, 2012 ... Vivus, based in Mountain View, Calif., is one of three small drugmakers racing to bring the first new prescription weight loss drug to market in ...
www.huffingtonpost.com/2012/02/23/fda-panel-backs-qnexa-pre_n_129...
Mar 7, 2012 ... Research presented to the FDA by Vivus, the company developing Qnexa, shows why the drug has a shot at approval: patients in a study lost ...
www.huffingtonpost.com/2012/03/06/diet-pill-qnexa-is-latest_n_132...
Feb 24, 2012 ... Vivus' Qnexa is one of a trio of drugs seeking FDA approval. The diet pill, which was initially rejected due to the risks of heart palpitations and ...
www.huffingtonpost.com/2012/02/24/diet-pill-safe-drug-qnexa_n_129...
Feb 17, 2012 ... Vivus, based in Mountain View, Calif., is one of three small drugmakers racing to bring the first new prescription weight loss drug to market in ...
www.huffingtonpost.com/2012/02/17/diet-pill-qnexas-safety-s_n_128...
Mar 21, 2012 ... Panelists did agree that Vivus should conduct additional studies to assess ... Pending FDA Approval for Vivus: Qnexa Weight-Loss Drug ...
www.huffingtonpost.com/gerard-e-mullin-md/qnexa-weight-loss_b_133...
Nov 18, 2009 ... NEW YORK — Shares of Vivus Inc. gained ground Wednesday after the company said its erectile dysfunction drug candidate avanafil reached ...
www.huffingtonpost.com/huff-wires/20091118/us-vivus-mover/